Arthritis News: Breaking Arthritis News, Comments and Articles. - Page: 3

Lipids Linked to Active Psoriatic Arthritis (CME/CE)

MADRID (MedPage Today) -- High disease activity in psoriatic arthritis is associated with elevated total cholesterol and triglycerides, adding to a growing body of evidence linking psoriatic arthritis metabolically with dyslipidemia and obesity, a re...

Magnetic Necklace Relieves Pain Announced Pain Free Living

Minneapolis-St. Paul, MN (PRWEB) June 16, 2013 Pain Free Living - SuperiorMagnetics.com an innovative leader in alternative pain relief announces new magnetic necklace for pain relief caused by headaches and arthritis. This new magnetic health n...

Week in Review: Mindray Medical Buys US Ultrasound Company for $105 Million

Mindray Medical will pay $105 million to acquire Zonare Medical Systems, a California high-end ultrasound device maker; Simcere Pharma announced a third drug development collaboration with Bristol-Myers Squibb for a biologic arthritis treatment; Jian...

China Biotech In Review: Mindray Medical Buys U.S. Ultrasound Company

By ChinaBio Today: Deals and Financings Mindray Medical (NYSE: MR) of Shenzhen will pay $105 million to acquire Zonare Medical Systems, a California high-end ultrasound machine maker (see story). Last year, Zonare had revenues of $64 million. Founded in 1999, Zonare claims its technology provides sharper images than competing machines. Ultrasound comprises one of Mindray's three major division...

Dr. Allen’s Device Can Protect People from Harmful Steroid Injections by Treating Lower Back Pain Naturally, Highlights Fine Treatment

According to the recent article in the WebMD, ‘Older women given steroids for spine-related pain showed a quicker rate of bone loss than other women their age, with a following vertebral fracture’. However, people can avoid putting themselves into potentially dangerous situations by using Dr. Allen’s device for lower spine treatment in the first place, states Fine Treatment. London, UK (PRWE...

Anti-TNF Doses Can Be Cut in Spinal Arthritis (CME/CE)

MADRID (MedPage Today) -- Many patients with ankylosing spondylitis who have low disease activity on treatment with tumor necrosis factor (TNF) inhibitors can reduce the dose of their biologic, a researcher said here.

hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Improved hCG Diet Plans Designed To Possibly Help Those Suffering From Obesity-Related Depression

Diet Doc now offers new medically designed and supervised prescription hCG diet plans that generate safe and rapid weight loss, capable of helping to improve poor self-image and self-esteem for those that suffer from weight-related depression. Miami, FL (PRWEB) June 15, 2013 Obesity can result in poor self-image, low self-esteem and social isolation, all components leading to depression, with man...

NSAID Use Raises Heart Risk in Arthritis (CME/CE)

MADRID (MedPage Today) -- Patients with rheumatoid arthritis and other inflammatory musculoskeletal diseases continue to be treated with nonsteroidal anti-inflammatory drugs, even with their high risk for ischemic heart disease, a researcher said her...

Drug Discontinuations Rampant in Rheumatoid Arthritis

In the modern era of biologics, up to one third of patients with rheumatoid arthritis still discontinue therapy within a year, most often because of lack of efficacy. Medscape Medical News

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced results from PALACE 3, the Company's third phase III study in psoriatic arthritis (PsA), at EULAR, the European Congress of Rheumatology ann...

Simcere Announces Third Drug Development Partnership with BMS

Simcere Pharma has formed a third drug development collaboration with Bristol-Myers Squibb. For the first time, the project involves a biologic molecule: a subcutaneous formulation of Orencia®, a treatment for rheumatoid arthritis. Orencia is alr...

The Impact Of Rheumatoid Arthritis On Joint Replacement Surgery Outcomes

Two new studies by researchers at Hospital for Special Surgery have shed light on joint replacement outcomes in patients with rheumatoid arthritis (RA). One study overturns the common belief that RA patients have worse outcomes after a total knee rep...

Deals of the Week Looks At How Amgen’s Global Expansion Affects Partnering

why yes, these are Japanese flip-flops, why do you ask? Amgen Inc. has made a big deal about expanding into Japan and eventually building a standalone subsidiary there. Now, the biotech’s Japanese expansion strategy is paying off for at least one o...

Will Generic Competitors Of Enbrel Affect Amgen's Stock Price?

By Bio Vantage:A recent clinical study comparing Enbrel with three generic drugs showed comparable efficacy and safety in rheumatoid arthritis patients (Therapies for Active Rheumatoid Arthritis after Methotrexate Failure NEJM 061113). Importantly, the cost of the triple therapy is $1000 compared with $25,000 for Enbrel. This begs the question of whether a switch to a generic combination, in the f...

Bristol-Myers and Simcere agree to co-developcommercialize Orencia SC in China

US pharma major Bristol-Myers Squibb (NYSE: BMY) and China-based Simcere Pharmaceutical (NYSE: SCR) have expanded their strategic relationship formed in 2010. The companies have agreed to collaborate in China on the co-development and commercializati...

Depression Key Reason to Stop Work with RA (CME/CE)

MADRID (MedPage Today) -- Depression was the strongest predictor of the decision by rheumatoid arthritis patients to apply for disability leave from work within a year of disease onset, a researcher said here.

Biologics Not Tx for Long Term? (CME/CE)

MADRID (MedPage Today) -- Despite the many biologics now available and the hope of more individualized therapy, half of U.S. patients with rheumatoid arthritis stopped these meds within 2 years, a large database analysis found.

No Long-Term Adherence for Biologics in RA? (CME/CE)

MADRID (MedPage Today) -- Despite the many biologics now available and the hope of more individualized therapy, half of U.S. patients with rheumatoid arthritis stopped these meds within 2 years, a large database analysis found.

Approval of Prograf® capsules in Japan for the additional indication of interstitial pneumonia associated with polymyositis /dermatomyositis

TOKYO, June 14, 2013 - Astellas Pharma Inc. (“Astellas”; Tokyo:4503; President and CEO: Yoshihiko Hatanaka) announced today that it has been granted approval in Japan for the additional indication of interstitial pneumonia associated wi...

Study Finds Individuals with Arthritis Don’t Walk Enough, Allsup Reports

Arthritis can be extremely debilitating; Allsup outlines considerations when applying for Social Security Disability Insurance benefits. Belleville, Ill. (PRWEB) June 14, 2013 A new study published by the Centers for Disease Control and Prevention (CDC) finds that most people with arthritis don’t walk enough or engage in adequate physical activity, both of which can help increase function and s...

Lilly, Incyte unveil data from Phase 2b JADA study of Baricitinib

Eli Lilly and Company and Incyte have unveiled 52-week efficacy and safety data from the long term extension of Phase 2b JADA study of baricitinib in patients with active rheumatoid arthritis (RA).

IntelliCell BioSciences Announces That Its Cellular Tissue Laboratory was inspected by FDA

NEW YORK, June 14, 2013 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTC Pink: SVFC) announced today that on May 14, 2013 through June 2, 2013, its cellular laboratory facility underwent a thorough inspection by the FDA. The observations from the FDA inspection were provided to the company in the Form 483. The Company will respond to those observations in a timely manner. Intell...

Stem Cells May Help Some With Avascular Necrosis (AVN)

TAMPA, Fla., June 14, 2013 /PRNewswire/ -- Stem cells have long been touted as the next big thing. Well just maybe, it is here.  According to Dr. Dennis Lox, some patients with a disorder of the bone called avascular necrosis (AVN), have turned to stem cell therapy for aid. Avascular necrosis (AVN) also referred to as osteonecrosis or ischemic necrosis, is a condition in which the blood...

Gemstone Magnetic Bracelet Relieves Arthritis Pain Announced Pain Free Living

Flint, Michigan (PRWEB) June 14, 2013 Pain Free Living web: SuperiorMagnetics.com, a leader in innovative in developing pain relief products is excited to announce a magnetic bracelet combined with gemstones that relieves pain caused by inflamma...

Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia® SC (abatacept) in China

Bristol-Myers Squibb Company (NYSE: BMY) and Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company in China, today announced that the companies have expanded their strategic relationship formed in 2010. The companies have agreed to collaborate in China on the development and commercializ